STOK compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

STOKStoke Therapeutics, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

STOKStoke Therapeutics, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only STOK 3

BIIBBiogen International GmbHcustomer

ACADAcadia Pharmaceuticalscustomer

—NWALP PHOP Property Ownerunlistedsupplier

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

25 more · LLY chain ›

STOKStoke Therapeutics, Inc.

26.52▲+1.72%· post 27.06

Mkt cap$1.7BRevenue$11MQ3 FY26Revenue$184MFY25

LLYELI Lilly & Co

1,360.90▼−0.28%· post 1,358.90

ClosedNov 6 '26

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

ClosedNov 6 '26

STOKStoke Therapeutics, Inc.

LLYELI Lilly & Co

26.52▲+1.72%post 27.06

Price

1,360.90▼−0.28%post 1,358.90

$1.7B

Mkt cap

$1.2T

Q3 FY26$11M

Revenue

$24.4BQ3 FY26

FY25$184M

Revenue

$65.2BFY25

STOK26.52▲+1.72%vsLLY1,360.90▼−0.28%ClosedNov 6 '26